Search Medical Condition
Please enter condition
Please choose location

Juan Diaz, Panama Clinical Trials

A listing of Juan Diaz, Panama clinical trials actively recruiting patients volunteers.

RESULTS

Found (18) clinical trials

This Study Will Evaluate the Persistence of Hepatitis A Antibodies 8 Years and 10 Years Later in Children Who Had Received Havrix at Selected Health Centres of Panama in 2007-2008

The study comprises of two independent cross-sectional surveys (Year 8 and Year 10). The first cross-sectional serosurvey will evaluate the long term persistence of immunity approximately 8 years post vaccine administration and the second cross-sectional study will evaluate long term persistence, approximately 10 years post vaccine administration.

Phase N/A

0.0 miles

Learn More »

A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies

This is a global, multicenter, open-label safety extension study. Participants receiving single-agent trastuzumab emtansine or trastuzumab emtansine administered in combination with other agents in a Genentech/Roche-sponsored parent study who are active and deriving benefit at the closure of parent study are eligible for continued treatment in this study.

Phase

5.45 miles

Learn More »

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

Children are placed into 1 of 4 treatment groups based on age: Group 1, 3 months to 24 months; Group 2, 25 months to 6 years; Group 3, 7 years to 12 years; Group 4, 13 years to 17 years. They receive baseline evaluations. Antiretroviral-naive patients receive emtricitabine plus stavudine ...

Phase

6.94 miles

Learn More »

A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)

This Phase II study will compare the efficacy and safety of obinutuzumab plus mycophenolate mofetil (MMF)/mycophenolic acid (MPA) with placebo plus MMF/MPA in participants with proliferative LN.

Phase

6.94 miles

Learn More »

IPV-102 Safety Tolerability and Immunogenicity of TAK-195 in Healthy Infants Toddlers and Adults

The drug being tested in this study is called sIPV. sIPV is used to prevent poliomyelitis. This study will look at the safety, tolerability of sIPV in healthy adults, toddlers and infants as well as immunogenicity in toddlers and infants. . The study will enroll approximately 340 participants including 40 ...

Phase

6.94 miles

Learn More »

A Study to Assess the Clinical Outcomes of Surgical Phaco Segmentation Techniques in Patients Undergoing Cataract Surgery

The purpose of this research study is to evaluate the clinical outcomes of different cataract surgical techniques for lens fragmentation in subjects undergoing routine cataract surgery.

Phase

6.94 miles

Learn More »

Safety and Immunogenicity of Takeda's TDV in Healthy Children

The vaccine being tested in this study is TDV. This study will look at cellular immune responses following TDV vaccination in dengue endemic regions. The study will enroll approximately 200 participants. Participants will receive: • TDV 0.5 mL subcutaneous (SC) injection All participants will receive 2-dose schedule of TDV by ...

Phase

6.94 miles

Learn More »

FLABRA: Frontline Approach for BRCA Testing in OC Treatment na ve Population. A LATIN AMERICA Epidemiologic Study

FLABRA is a cross-sectional, multi-center, epidemiological observational study designed to evaluate the prevalence of BRCA mutations in newly diagnosed ovarian cancer patients across understudied ethnic groups in Latin America. Secondary objectives of the study are to evaluate the prevalence of sBRCAm versus gBRCAm in newly diagnosed ovarian cancer patients and ...

Phase N/A

6.94 miles

Learn More »

Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis

The proposed study will assess primarily safety and secondary efficacy endpoints of allogeneic UC-MSC administered to 20 patients with disease modifying antirheumatic drug (DMARD)-resistant Rheumatoid Arthritis (RA) who have been non-responsive to at least one course of one DMARD selected from a group comprising of: gold salts, leflunomide, methotrexate, and ...

Phase

6.94 miles

Learn More »

MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications

The study will evaluate the efficacy and safety of the implant and IOP lowering effects with or without glaucoma medications. The procedure will be a stand-alone surgery. Overall, the patient will be asked to perform several examinations up to 24 months after surgery. The primary efficacy objective of the present ...

Phase N/A

6.94 miles

Learn More »